Tirzepatide

Price range: $175.00 through $350.00

Tirzepatide, a synthetic dual agonist peptide, has become a prominent subject in peptide research for its ability to engage both GLP-1 and GIP receptors, providing researchers with a versatile model for studying multi-receptor signaling and metabolic pathway crosstalk in controlled environments.

Description

Overview

Tirzepatide is a synthetic peptide designed to simultaneously activate glucagon-like peptide-1 (GLP-1) receptors and glucose-dependent insulinotropic polypeptide (GIP) receptors. This dual receptor affinity has made Tirzepatide a valuable research tool for exploring the complex interplay between incretin signaling pathways. Researchers are particularly interested in how dual agonism influences receptor crosstalk, intracellular signaling dynamics, and tissue-specific responses in metabolic and endocrine systems.

With its extended half-life and balanced receptor affinity, Tirzepatide allows for controlled exploration of multi-receptor peptide therapeutics and the challenges of coordinating signals from distinct receptor families. Its structure-activity relationship (SAR) studies help map how small modifications affect peptide stability, receptor selectivity, and downstream biological responses, making it a key subject for advancing multi-target peptide research.

Areas of Research

• Studies exploring dual agonism at GLP-1 and GIP receptors in metabolic regulation models.

• Investigation into peptide-receptor crosstalk and combinatorial signaling effects.

• Research into structure-activity relationships (SAR) optimizing receptor affinity and peptide stability.

• Examination of multi-receptor agonists for tissue-specific signaling modulation.

• Analysis of peptide pharmacokinetics and degradation profiles in preclinical systems.

Notes & Considerations

• Tirzepatide’s dual receptor profile offers a novel model for studying the challenges and opportunities of polyagonist peptide design.

• Researchers are investigating how changes in peptide sequence influence binding affinity at each receptor, as well as the downstream signaling balance.

• Comparative studies with single-receptor agonists (GLP-1 or GIP-only) provide valuable insights into the potential synergistic or competitive effects of multi-receptor targeting.

• Ongoing research focuses on how tissue-specific receptor expression patterns influence the effects of dual agonism in different biological contexts.

Additional information

Weight N/A
Dimensions N/A
Size

20mg, 50mg

Reviews

There are no reviews yet.

Be the first to review “Tirzepatide”

Your email address will not be published. Required fields are marked *